SEC Form 4 · accession 0001171843-17-000452
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Arthur Eldridge
Officer — Snr VP,CFO,Treasurer,Asst Secy
Period of report
Jan 24, 2017
Accepted (ET)
Jan 26, 2017 · 8:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.05 | Jan 24, 2017 | A | 53,119 | A | — | Jan 23, 2027 | Common Stock, $0.001 par value | 53,119 | 53,119 | D |
Explanation of responses
- F1The options were granted on January 24, 2017 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments.